DalsnaFinance › IPOs › Apogee Therapeutics Inc › IPO
Apogee Therapeutics, Inc. completed its initial public offering on NASDAQ on July 14, 2023, pricing at $17.00 a share.
| Ticker | APGE |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 14, 2023 |
| Offering price | $17.00 |
| Shares offered | 17,650,000 |
| Total raised | $300M |
Apogee Therapeutics, Inc. sold 17,650,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $300.1 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $300 million total recorded for the deal.
Apogee Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Apogee Therapeutics, Inc.. This page is general information, not investment advice.